Veracyte, Inc.
General ticker "VCYT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6B (TTM average)
Veracyte, Inc. follows the US Stock Market performance with the rate: 50.7%.
Estimated limits based on current volatility of 2.8%: low 34.77$, high 36.73$
Factors to consider:
- Total employees count: 824 (+1.1%) as of 2024
- US accounted for 95.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Regulatory and compliance, Market competition, Cybersecurity threats, Geopolitical risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [32.57$, 50.82$]
- 2026-12-31 to 2027-12-31 estimated range: [33.06$, 52.08$]
Financial Metrics affecting the VCYT estimates:
- Positive: with PPE of 23.8 at the end of fiscal year the price was neutral
- Positive: 7.67 < Operating profit margin, % of 14.34
- Positive: Investing cash flow per share per price, % of -0.28 > -0.63
- Positive: Inventory ratio change, % of -0.70 <= 0
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.51
- Positive: 0.01 < Operating cash flow per share per price, % of 4.07
- Negative: negative Industry operating income (median)
Short-term VCYT quotes
Long-term VCYT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $361.05MM | $445.76MM | $517.14MM |
| Operating Expenses | $446.85MM | $429.62MM | $443.00MM |
| Operating Income | $-85.80MM | $16.14MM | $74.15MM |
| Non-Operating Income | $9.18MM | $9.60MM | $-5.95MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $57.30MM | $69.29MM | $70.81MM |
| Income(Loss) | $-76.61MM | $25.74MM | $68.20MM |
| Taxes | $-2.21MM | $1.61MM | $1.85MM |
| Profit(Loss)* | $-74.40MM | $24.14MM | $66.35MM |
| Stockholders Equity | $1,044.10MM | $1,175.97MM | $1,309.58MM |
| Inventory | $16.13MM | $21.75MM | $20.55MM |
| Assets | $1,114.91MM | $1,300.04MM | $1,406.02MM |
| Operating Cash Flow | $44.22MM | $75.10MM | $136.31MM |
| Capital expenditure | $9.96MM | $11.29MM | $9.68MM |
| Investing Cash Flow | $15.11MM | $-56.27MM | $-9.21MM |
| Financing Cash Flow | $2.84MM | $4.90MM | $-4.22MM |
| Earnings Per Share** | $-1.02 | $0.32 | $0.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.